Related Articles
BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer
Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model
Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancer
Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme
Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer